THe LAW AND ECONOMICS of DRUG DEVELOPMeNt
November 7, 2008University of Michigan Law School,Hutchins Hall, Room 250Ann Arbor, MichiganFree and open to the public
New drugs promise to prolong and improve the quality of human lives. But, as the cost of new drug development increases, policy makers face difficult tradeoffs. This symposium will address some of the most pressing policy questions facing FDA, Congress, and the courts, including:
Participants in the Conference include: Robert Armitage (Senior Vice President and General Counsel, Eli Lilly & Co.), Omri Ben-Shahar (Professor, Univ. of Chicago), Rebecca Eisenberg (Professor, Univ. of Michigan), Scott Hemphill (Professor, Columbia Univ.), Peter Barton Hutt (Senior Counsel, Covington & Burling LLP), Ariel Katz (Professor, Univ. of Toronto), Frank Lichtenberg (Professor, Columbia Univ.), Lars Noah (Professor, Univ. of Florida), Mary Olson (Professor, Tulane Univ.), Ben Roin (Professor, Harvard Univ.), Catherine Sharkey (Professor, NYU), Scott Stern (Professor, Northwestern Univ.), Qing Zhang (Professor, China Univ. of Pol. Sci. & Law). Sponsored by the Program in Law, Economics, & Technology and Michigan Telecommunications & Technology Law Review, with generous funding from the Microsoft Corporation.
Welcome Remarks - Rebecca Eisenberg
Panel on Regulatory Initiatives (Omri Ben-Shahar, Moderator)Ariel KatzFrank LichtenbergMary OlsonScott SternQing Zhang
Remarks (Afternoon Session)
Panel on Alternative Perspectives on IP Regimes (Peter Barton Hutt, Moderator)Robert ArmitageRebecca EisenbergScott HemphillBen Roin
Panel on Federal Preemption and Torts (Rebecca Eisenberg, Moderator)Lars NoahCatherine Sharkey
Comments/Suggestions | Site Map | Work Requests | Admin Portal | Disclaimer | Supported Browsers | U of M Home
Regents of the
University of Michigan. All images property of Michigan Law
The University of Michigan Law School.
625 South State Street,
Ann Arbor, Michigan
48109-1215 USA - Contact Us